REGISTERED
on 19 Oct 2021
Last Applicant/ Owned by
5500 Central Avenue, Suite 220
Boulder
CO
80301
Serial Number
88673620 filed on 30th Oct 2019
Registration Number
6531420 registered on 19th Oct 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
INSCRIPTA THE DIGITAL GENOME ENGINEERING COMPANY
Reagents and kits comprising reagents for scientific or research use in connection with cell manipulation, cell transformation, genomic editing and genomic editing analysis Scientific and laboratory apparatus and instruments for manipulating cells and editing genomes
Classification Information
Class [009]
Computer & Software Products & Electrical & Scientific Products
Scientific and laboratory apparatus and instruments for manipulating cells and editing genomes
First Use Date in General
19th Mar 2021
First Use Date in Commerce
19th Mar 2021
Class [001]
Chemical Products
Reagents and kits comprising reagents for scientific or research use in connection with cell manipulation, cell transformation, genomic editing and genomic editing analysis
First Use Date in General
19th Mar 2021
First Use Date in Commerce
19th Mar 2021
Mark Details
Serial Number
No 88673620
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 39730.00014
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Jun 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 27th Jun 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 27th Jun 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 27th Jun 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 27th Jun 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 19th Oct 2021 | REGISTERED-PRINCIPAL REGISTER |
| 16th Sep 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 15th Sep 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 26th Aug 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| 25th Aug 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |